⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19089959 | 0.76 | — | — | |
| SCHEMBL26350611 | 0.72 | — | — | |
| SCHEMBL20145700 | 0.70 | — | — | |
| SCHEMBL22990344 | 0.70 | — | — | |
| SCHEMBL19787752 | 0.70 | — | — | |
| SCHEMBL22314320 | 0.69 | — | — | |
| SCHEMBL23768628 | 0.69 | — | — | |
| SCHEMBL22249922 | 0.69 | — | — | |
| SCHEMBL14839251 | 0.67 | — | — | |
| SCHEMBL21922826 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021026672-A1 | HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS | NOVARTIS AG (CH) | 2021-02-18 | — | — | WO | disclosed |